Back to Results

IO Biotech Inc (IOBTQ)

-


Stock Summary Fair Value Profitability & Growth Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Dividend Yield Next Earnings Date Market Cap Free Float / Shares Outstanding
OTC-IOBT.Q
Not available
$4 199,900.0% Upside
Not available
Bargain
0.0%
November 12, 2026
7.194 K
69.0%
Valuation • Fair Value

IO Biotech Inc (OTC-IOBT.Q) Fair Value by Valuation Model

Review the valuation references currently available for IO Biotech Inc (OTC-IOBT.Q).

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

$4 199,900.0% Upside

Current consensus analyst target, where available.

How to read these valuation models

Use the available valuation reference for IO Biotech Inc (OTC-IOBT.Q) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for IO Biotech Inc (OTC-IOBT.Q)

Review the profitability and growth indicators currently supported by the latest data.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

-91.802 M

Current operating profitability reference.

EBITDA Forecast

-70.365 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review IO Biotech Inc (OTC-IOBT.Q) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Events • Dividends

Upcoming Events & Dividends for IO Biotech Inc (OTC-IOBT.Q)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 12, 2026

Days to Earnings

55

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for IO Biotech Inc (OTC-IOBT.Q), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

IO Biotech Inc (OTC-IOBT.Q) Stock Forecast & Technical Outlook

Review IO Biotech Inc (OTC-IOBT.Q) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for IO Biotech Inc (OTC-IOBT.Q) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for IO Biotech Inc (OTC-IOBT.Q) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for IO Biotech Inc (OTC-IOBT.Q) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for IO Biotech Inc (OTC-IOBT.Q) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for IO Biotech Inc (OTC-IOBT.Q) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for IO Biotech Inc (OTC-IOBT.Q)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, IO Biotech Inc (OTC-IOBT.Q) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

IO Biotech Inc (OTC-IOBT.Q) Stock FAQ

Data-supported answers about IO Biotech Inc (OTC-IOBT.Q), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Analyst Target
$4 199,900.0% Upside
Data is currently unavailable

A reliable fair value estimate is not currently available for IO Biotech Inc (OTC-IOBT.Q). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The available analyst price target for IO Biotech Inc (OTC-IOBT.Q) is $4 199,900.0% Upside.

The next earnings date currently listed for IO Biotech Inc (OTC-IOBT.Q) is November 12, 2026.

The latest available data indicates no current dividend yield for IO Biotech Inc (OTC-IOBT.Q).

The current market capitalization listed for IO Biotech Inc is 7.194 K.

The ticker symbol for IO Biotech Inc is OTC-IOBT.Q, and the stock is listed on OTC Markets.

IO Biotech Inc (OTC-IOBT.Q) is listed on OTC Markets.

The free float listed for IO Biotech Inc is 69.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Biotechnology Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

ABBV NYSE AbbVie Inc Fair Value Fair Market Cap 466.4 B
AMGN NASDAQ Amgen Inc Fair Value Fair Market Cap 208.5 B
GILD NASDAQ Gilead Sciences Inc Fair Value Fair Market Cap 186 B
VRTX NASDAQ Vertex Pharmaceuticals Inc Fair Value Fair Market Cap 128.8 B
REGN NASDAQ Regeneron Pharmaceuticals Inc Fair Value Undervalued Market Cap 78.353 B
ARGX NASDAQ argenx NV ADR Fair Value Fair Market Cap 62.595 B
MRNA NASDAQ Moderna Inc Fair Value Overvalued Market Cap 61.522 B
NTRA NASDAQ Natera Inc Fair Value Overvalued Market Cap 53.245 B
RVMD NASDAQ Revolution Medicines Inc Fair Value Fair Market Cap 40.928 B
ONC NASDAQ BeOne Medicines AG DRC Fair Value Fair Market Cap 39.9 B
ALNY NASDAQ Alnylam Pharmaceuticals Inc Fair Value Fair Market Cap 32.055 B
BIIB NASDAQ Biogen Inc Fair Value Fair Market Cap 31.841 B
ROIV NASDAQ Roivant Sciences Ltd Fair Value Overvalued Market Cap 28.748 B
INSM NASDAQ Insmed Inc Fair Value Fair Market Cap 26.206 B
INCY NASDAQ Incyte Corporation Fair Value Fair Market Cap 25.4 B
BNTX NASDAQ BioNTech SE Fair Value Fair Market Cap 24.131 B
UTHR NASDAQ United Therapeutics Corporation Fair Value Fair Market Cap 21.214 B
GMAB NASDAQ Genmab AS Fair Value Overvalued Market Cap 20.751 B
ASND NASDAQ Ascendis Pharma AS Fair Value Fair Market Cap 15.546 B
NBIX NASDAQ Neurocrine Biosciences Inc Fair Value Undervalued Market Cap 14.864 B